title: Infliximab-induced eczematoid eruption.
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Martín
authors.forename: M
authors.initials: M
authors.lastname: Sáez
authors.forename: A
authors.initials: A
authors.lastname: Carnerero
authors.forename: M
authors.initials: M
authors.lastname: García-Bustínduy
authors.forename: A
authors.initials: A
authors.lastname: Guimerá
authors.forename: F
authors.initials: F
authors.lastname: Rodríguez García
authors.forename: R
authors.initials: R
authors.lastname: Cabrera de Paz
authors.forename: M
authors.initials: M
authors.lastname: Sidro
authors.forename: R
authors.initials: R
authors.lastname: Sánchez
authors.forename: A
authors.initials: A
authors.lastname: Martín Herrera
authors.forename: A
authors.initials: A
authors.lastname: Noda
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003875:Drug Eruptions; D004485:Eczema / Q000139:chemically induced*; D004890:Erythema / Q000473:pathology; D005260:Female; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab